Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katherine A Araque

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
The Lancet. Oncology|November 5, 2020
Comprehensive guidance on the diagnosis and management of primary mesenchymal tumours of the thyroid glandSriram Gubbi, Shilpa Thakur, Shirisha Avadhanula, et al.
Pituitary|July 3, 2021
Complication avoidance protocols in endoscopic pituitary adenoma surgery: a retrospective cohort study in 514 patientsJai Deep Thakur, Alex Corlin, Regin Jay Mallari, et al.
The Lancet. Diabetes & Endocrinology|February 23, 2026
Efficacy and safety of relacorilant for the treatment of patients with Cushing's syndrome (GRACE): a multicentre, phase 3, double-blind, placebo-controlled, randomised-withdrawal studyRosario Pivonello, Giorgio Arnaldi, Richard J Auchus, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
The Lancet. Oncology|November 5, 2020
Comprehensive guidance on the diagnosis and management of primary mesenchymal tumours of the thyroid glandSriram Gubbi, Shilpa Thakur, Shirisha Avadhanula, et al.
Pituitary|July 3, 2021
Complication avoidance protocols in endoscopic pituitary adenoma surgery: a retrospective cohort study in 514 patientsJai Deep Thakur, Alex Corlin, Regin Jay Mallari, et al.
The Lancet. Diabetes & Endocrinology|February 23, 2026
Efficacy and safety of relacorilant for the treatment of patients with Cushing's syndrome (GRACE): a multicentre, phase 3, double-blind, placebo-controlled, randomised-withdrawal studyRosario Pivonello, Giorgio Arnaldi, Richard J Auchus, et al.
Pageof 2